Skip to content
FORSIDEN
Log ind Opret konto
  • Kategorier
  • Seneste
  • Etiketter
  • Populære
  • Verden
  • Bruger
  • Grupper
Temaer
  • Light
  • Brite
  • Cerulean
  • Cosmo
  • Flatly
  • Journal
  • Litera
  • Lumen
  • Lux
  • Materia
  • Minty
  • Morph
  • Pulse
  • Sandstone
  • Simplex
  • Sketchy
  • Spacelab
  • United
  • Yeti
  • Zephyr
  • Dark
  • Cyborg
  • Darkly
  • Quartz
  • Slate
  • Solar
  • Superhero
  • Vapor

  • Default (No Skin)
  • No Skin
Kollaps
  1. Debatforum
  2. Kategorier
  3. Hansa Biopharma
  4. Hansa Biopharma — April 2023

Hansa Biopharma — April 2023

Planlagt Fastgjort Låst Flyttet Hansa Biopharma
46 Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • exitnuE Offline
    exitnuE Offline
    exitnu
    wrote on sidst redigeret af
    #37

    Penser Access: Ljusning i horisonten- Hansa Biopharma

    Link Preview Image
    Penser Access: Ljusning i horisonten- Hansa Biopharma

    Q1 - något svagare finansiellt Hansa levererade under torsdagen sin Q1-rapport. Finansiellt kom rapporten in något under våra förväntningar. Omsättningen landade på 24 mkr (EPB est: 28 mkr),...

    favicon

    MFN (mfn.se)

    1 Reply Last reply
    0
    • exitnuE Offline
      exitnuE Offline
      exitnu
      wrote on sidst redigeret af
      #38

      "Vårt motiverade värde är fortsatt 210–220 kronor per aktie."

      Läs den fullständiga analysen, publicerad 21-04-2023 kl. 08:48: https://docs.penser.se/a/3636/HNSA20230421_PDF.pdf

      Detta är ett pressmeddelande från Erik Penser Bank. Läs mer på https://epaccess.penser.se/

      1 Reply Last reply
      0
      • P Offline
        P Offline
        ProinvestorNEWS
        wrote on sidst redigeret af
        #39

        Presentation from Thursday around Gene Therapy by our Global Franchise Lead Lena Winstedt (in Swedish): https://www.proinvestor.com/boards/112225

        1 Reply Last reply
        0
        • P Offline
          P Offline
          ProinvestorNEWS
          wrote on sidst redigeret af
          #40

          I linket er også seks opdateringer fra analytikere.

          1 Reply Last reply
          0
          • L Offline
            L Offline
            LP90
            wrote on sidst redigeret af
            #41

            Godmorgen 🙂 bliver dejligt når vi når Penser Bank kursmål

            1 Reply Last reply
            0
            • P Offline
              P Offline
              ProinvestorNEWS
              wrote on sidst redigeret af
              #42

              Hansa Biopharma - Presentation of Q1
              interim report 2023

              Hansa Biopharma published its Q1 report on April 20th.

              On that occasion, HC Andersen Capital will be hosting a digital event on Monday, April 24th at 13.00 https://www.inderes.dk/videos/inderes-presentation-of-q1-2023

              1 Reply Last reply
              0
              • Helge_LarsenPI-redaktørH Offline
                Helge_LarsenPI-redaktørH Offline
                Helge_LarsenPI-redaktør
                wrote on sidst redigeret af
                #43

                The Chicago-based investment bank "William Blair" (analyst Matt Phipps) has initiated coverage on Hansa Biopharma

                Hansa Biopharma AB (HNSA) - Turning the TIdeS: Imlifidase Provides a Novel Solution to Widen Transplant Access and Treat Antibody-Driven Acute Disease. https://www.proinvestor.com/boards/112225/

                1 Reply Last reply
                0
                • P Offline
                  P Offline
                  ProinvestorNEWS
                  wrote on sidst redigeret af
                  #44

                  Kort video - Pharma og biotek-opdatering UGE 17: Demant ' GN Store Nord ' Novo Nordisk ' Genmab ' Zealand Pharma ' Hansa Biopharma https://www.proinvestor.com/boards/112327

                  1 Reply Last reply
                  0
                  • exitnuE Offline
                    exitnuE Offline
                    exitnu
                    wrote on sidst redigeret af
                    #45

                    Hansa Biopharma and Genethon announce collaboration to develop imlifidase as pre-treatment to gene therapy in Crigler-Najjar syndrome patients with anti-AAV antibodies

                    Link Preview Image
                    Hansa Biopharma and Genethon announce collaboration to develop imlifidase as pre-treatment to gene therapy in Crigler-Najjar syndrome patients with anti-AAV antibodies | Hansa Biopharma

                    favicon

                    (www.hansabiopharma.com)

                    1 Reply Last reply
                    0
                    • L Offline
                      L Offline
                      LP90
                      wrote on sidst redigeret af
                      #46

                      Godmorgen 🙂

                      1 Reply Last reply
                      0
                      • L Offline
                        L Offline
                        LP90
                        wrote on sidst redigeret af
                        #47

                        Spændende med det nye samarbejde nu må det også gerne snart afspejles i kursen med de aftaler og samarbejder de indgår 🙂

                        1 Reply Last reply
                        0

                        Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                        Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                        With your input, this post could be even better 💗

                        Tilmeld Log ind
                        Svar
                        • Svar som emne
                        Login for at svare
                        • Ældste til nyeste
                        • Nyeste til ældste
                        • Most Votes


                        • Log ind

                        • Har du ikke en konto? Tilmeld

                        • Login or register to search.
                        Powered by NodeBB Contributors
                        • First post
                          Last post
                        0
                        • Kategorier
                        • Seneste
                        • Etiketter
                        • Populære
                        • Verden
                        • Bruger
                        • Grupper